SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Washington University in St. Louis Research: Poxvirus’ Ability to Hide From The Immune System May Aid Vaccine Design
November 15, 2007
 · 
1 min read
Drug Development
Stem Cell Shots Restore Lost Memory
November 9, 2007
 · 
1 min read
Drug Development
D-Cycloserine Reduces Cocaine-Seeking Behavior in “Addicted” Mice
November 7, 2007
 · 
1 min read
Drug Development
Case Western Reserve University Researchers Breed A Mighty Mouse
November 2, 2007
 · 
1 min read
Drug Development
Mice Predict The Effectiveness Of Orally Taken Drugs
November 2, 2007
 · 
1 min read
Drug Development
Radio Waves Fire Up Nanotubes Embedded in Tumors, Destroying Liver Cancer
November 2, 2007
 · 
1 min read
Drug Development
Epilepsy-induced Brain Cell Damage Prevented In The Laboratory
October 30, 2007
 · 
1 min read
Drug Development
University of Michigan Scientists Find New Causes For Neurodegeneration
October 29, 2007
 · 
1 min read
Drug Development
Mice Help Researchers Understand Chlamydia
October 29, 2007
 · 
1 min read
Drug Development
University of Georgia Researchers One Step Closer to Cancer Vaccine
October 29, 2007
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Biomica Announces Positive Pre-Clinical Results, Demonstrating Efficacy of BMC128 in Melanoma
April 13, 2021
 · 
7 min read
Drug Development
Ascentage Pharma Releases Preclinical Data of Its Core Drug Candidates at AACR Annual Meeting 2021, with Results Signifying the Potential of Multiple Combination Therapies in Cancer
April 12, 2021
 · 
12 min read
Drug Development
Antengene Presented Preclinical Data Demonstrating Potent Synergistic Effect of the Combination of ATG-010 (Selinexor) and ATG-008 (Onatasertib) for the Treatment of Triple-Hit DLBCL
April 12, 2021
 · 
3 min read
Drug Development
Tevogen Bio to Present Preclinical Data of TVGN-489, its Investigational Allogeneic Cytotoxic T Cell Therapy for COVID-19, at the 2021 Annual Meeting of American Association of Immunologists
April 12, 2021
 · 
3 min read
Drug Development
SOTIO Demonstrates Strong Potential of SOT102 (ADC Targeting Claudin 18.2) for Treatment of Solid Tumors in Preclinical Studies
April 12, 2021
 · 
2 min read
Drug Development
Genprex Collaborators Report Positive Preclinical Data for REQORSA™ Immunogene Therapy in Non-Small Cell Lung Cancer at the 2021 AACR Annual Meeting
April 12, 2021
 · 
8 min read
Drug Development
Schrödinger Reports Preclinical Data on Novel, Selective CDC7 Inhibitors Presented at American Association for Cancer Research Annual Meeting
April 12, 2021
 · 
7 min read
Drug Development
Morphic Therapeutic Presents Preclinical Data from αvβ8 Integrin Program at American Association for Cancer Research (AACR) Annual Meeting
April 12, 2021
 · 
4 min read
Drug Development
Amunix Presents Preclinical Data at American Academy of Cancer Research (AACR) Annual Meeting from Lead Program AMX-818 Demonstrating Robust Efficacy in HER2 Tumor Models and Enhanced Safety
April 12, 2021
 · 
4 min read
Drug Development
PYC Therapeutics Announces Preclinical Data Demonstrating Superior PPMO Delivery to the Brain
April 12, 2021
 · 
7 min read
Drug Development
Oncolytics Biotech® Presents Preclinical Data on Pelareorep-based Combination Therapies at the AACR Annual Meeting
April 12, 2021
 · 
6 min read
Drug Development
Medicenna Presents Preclinical Data Demonstrating Potent Immune Modulating Effects of an IL-2/IL-13 Dual Specific Cytokine at the 2021 AACR Annual Meeting
April 12, 2021
 · 
5 min read
Drug Development
Bio-Path Holdings Presents BP1002 Data at 2021 American Association for Cancer Research Annual MeetingPreclinical Data Support BP1002 Combination Therapy in Venetoclax-resistant AML Patients
April 12, 2021
 · 
4 min read
Drug Development
Valbiotis Reveals Positive TOTUM•854 Preclinical Results in the Prevention of Hypertension at the Annual ESH-ISH Joint Meeting
April 12, 2021
 · 
10 min read
Drug Development
Ascletis Announced Four Clinical and Preclinical Study Abstracts of NASH and HBV Accepted as Poster Presentations by the International Liver Congress™ 2021
April 11, 2021
 · 
5 min read
Drug Development
C4 Therapeutics Presents Preclinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the AACR Annual Meeting 2021
April 10, 2021
 · 
6 min read
Drug Development
Mirati Therapeutics Presents Preclinical Data on Novel Approach to PRMT5 Inhibition that Selectively Targets the PRMT5/MTA Complex in MTAP-Deleted Cancer Models
April 10, 2021
 · 
5 min read
Drug Development
Pieris Pharmaceuticals Presents Updated Phase 1 Monotherapy Data for 4-1BB/HER2 Bispecific Cinrebafusp Alfa and Preclinical Data for 4-1BB/PD-L1 Bispecific PRS-344/S095012 at 2021 AACR Annual Meeting
April 10, 2021
 · 
8 min read
Drug Development
PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021
April 10, 2021
 · 
4 min read
Drug Development
Jubilant Therapeutics Presents Preclinical Data on its Brain Penetrant PRMT5 Inhibitor and Small Molecule PD-L1 Inhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2021
April 10, 2021
 · 
4 min read
Load More